{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-035331","form_type":"8-K","ticker":"INBP","cik":"0001016504","company_name":"INTEGRATED BIOPHARMA INC","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.385062+00:00","generated_at":"2026-05-30T00:11:34.835015+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Integrated BioPharma Q1 revenue $13.6M (+5.4% YoY); net income $0.3M vs loss","bullets":["Revenue $13.6M versus $12.9M YoY; operating income $0.5M versus operating loss of $54K.","Net income $259K ($0.01 diluted EPS) compared to net loss of $59K ($0.00) in prior year.","Two largest customers represented 85% of revenue (down from 91%), reflecting diversification.","No forward guidance or dividend changes were provided in the release."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-035331","json":"https://secwatch.observer/filing/0001437749-24-035331.json","markdown":"https://secwatch.observer/filing/0001437749-24-035331.md","text":"https://secwatch.observer/filing/0001437749-24-035331.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1016504/000143774924035331/0001437749-24-035331-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1016504/000143774924035331/inbp20241112_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:11:34.835015+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}